Equities

Key statistics

Abbott Laboratories (ABT:NYQ) set a new 52-week high during Thursday's trading session when it reached 49.59. Over this period, the share price is up 29.81%.
52-week range
Today
36.76Jun 27 201649.59Jun 22 2017
Markit short selling activity
Low
Med
High
Open49.18
High49.28
Low48.99
Bid49.21
Offer49.22
Previous close49.27
Average volume8.19m
Shares outstanding1.74bn
Free float1.72bn
P/E (TTM)54.70
Market cap85.50bn USD
EPS (TTM)0.9008
USD
Annual div (ADY)1.06
USD
Annual div yield (ADY)2.15%
Div ex-dateApr 11 2017
Div pay-dateMay 15 2017
Next div ex-dateJul 12 2017
Next div pay-dateAug 15 2017
Data delayed at least 15 minutes, as of Jun 23 2017 18:06 BST.
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.